Results 81 to 90 of about 5,346,158 (173)
Blastic plasmacytoid dendritic cell neoplasm of the skin associated with myelodysplastic syndrome [PDF]
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a recently described, rare hematologic malignancy with prominent skin involvement. The prognosis of this disease is poor in most cases, with rapid progression despite chemotherapy administration ...
Sang, Hong +16 more
core +1 more source
Introduction Acute myeloid leukemia (AML) with plasmacytoid dendritic cell differentiation (pDC‐AML) is a newly described subtype of leukemia with features resembling blastic plasmacytoid dendritic cell neoplasm (BPDCN).
Benjamin J. Lee +5 more
doaj +1 more source
Key Clinical Message Blastic plasmacytoid dendritic cell neoplasm is a rare hematologic malignancy and appropriate diagnosis encounters difficulties in both clinical and pathologic aspects.
Ramtin Edjtemaei +2 more
doaj +1 more source
Abstracts submitted to the ‘EACR 2026 Congress: Innovative Cancer Science’, from 08–11 June 2026 and accepted by the Congress Organising Committee are published in this Supplement of Molecular Oncology, an affiliated journal of the European Association for Cancer Research (EACR).
wiley +1 more source
Blastic plasmacytoid dendritic cell neoplasm is a malignant, aggressive, and rare tumor arising from plasmacytoid dendritic cell precursors. Because of its infrequency, information on clinical features and best treatment options is still lacking ...
Daniel Argüello-Ruiz +2 more
doaj
CD4+/CD56+ hematodermic neoplasm (WHO-EORTC) or blastic NK-cell lymphoma (WHO) is a rare aggressive (CD4+)(CD56+)lin- skin-tropic lymphoma of putative early-plasmacytoid dendritic cell origin.
AP Ng +5 more
doaj
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare and aggressive hematologic malignancy that usually occurs in elderly individuals and manifests with skin lesions followed by involvement of the lymph nodes, bone marrow, and peripheral blood.
Ming-Ying Wu +3 more
core +1 more source
Blastic plasmacytoid dendritic cell neoplasm mimicking dermatomyositis
Christopher J. Fay, BA +4 more
doaj +1 more source
International audienceWe describe the use and value of a lenalidomide/bortezomib/dexamethasone regimen for the treatment of three patients with blastic plasmacytoid dendritic cell neoplasm (BPDCN, a disease that lacks a consensus treatment).
Marmouset, Vincent +13 more
core +1 more source
Pseudo-Rosette-Forming Blastic Plasmacytoid Dendritic Cell Neoplasm
Praveen Sharma, Shano Naseem
doaj +1 more source

